Insomnia and elevated risk of major depressive disorder in older adult, long-term breast cancer survivors vs a matched cohort
SLEEPJ · 2026
DOI: 10.1093/sleep/zsaf322 ↗Kurz gefasst
Fachartikel in der Zeitschrift SLEEPJ, 2026. Verfasst von Michael R Irwin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Breast Neoplasms, Major Depressive Disorder, Cancer Survivors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, NIH.
Themen: Schlaf
Abstract (Originalsprache)
Study Objectives Depression frequently occurs after diagnosis of breast cancer diagnosis. This study examines the incidence of depression and whether insomnia exaggerates depression risk in long-term breast cancer survivors (BCSs).
Methods
A sample of 636 nondepressed females, aged 55 to 85 years, was recruited between 2015 and 2020 from a diverse community-based health plan; 315 were BCSs at least 2 years postdiagnosis, and 321 were an aged-matched comparison cohort. Both groups were stratified by the presence or absence of insomnia at baseline. The primary outcome, incident and recurrent major depressive disorder, was diagnosed over 32 months. Cox proportional hazards models estimated risk of depression (hazard ratio [HR], 95% confidence interval [CI]).
Results
A total of 310 (98.4%) BCSs, and 309 (96.3%) comparisons completed 32 months follow-up. Relative to the comparisons, risk of depression was elevated in BCSs (HR = 5.94; 95% CI = 3.34% to 10.54%, p < .001). Insomnia, as defined by the Insomnia Severity Index (>8), further increased depression risk BCS (HR = 9.91; 95% CI = 4.92% to 19.96%; p < .001), but not in the comparisons.
Conclusions
Long-term BCSs have a heightened risk of major depressive disorder, and even subthreshold insomnia exaggerates that risk. Given that insomnia treatment can effectively prevent depression, insomnia screening and treatment have implications for depression prevention in BCSs. Statement of Significance Breast cancer survivors with insomnia show a markedly elevated risk of depression, which supports the urgent need to screen for insomnia in cancer survivors and to develop and implement insomnia treatment to prevent depression in this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
- Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
- Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
ORCID-Profile: Reina Haque
Förderung
- NCI NIH HHS
- National Cancer Institute
- NIH
Zitieren
APA
Irwin, M. R., Olmstead, R., Chen, L., & Haque, R. (2026). Insomnia and elevated risk of major depressive disorder in older adult, long-term breast cancer survivors vs a matched cohort. SLEEPJ. https://doi.org/10.1093/sleep/zsaf322
Vancouver
Irwin MR, Olmstead R, Chen L, Haque R. Insomnia and elevated risk of major depressive disorder in older adult, long-term breast cancer survivors vs a matched cohort. SLEEPJ. 2026. doi:10.1093/sleep/zsaf322
BibTeX
@article{Irwin2026,
author = {Irwin, Michael R and Olmstead, Richard and Chen, LieHong and Haque, Reina},
title = {Insomnia and elevated risk of major depressive disorder in older adult, long-term breast cancer survivors vs a matched cohort},
journal = {SLEEPJ},
year = {2026},
doi = {10.1093/sleep/zsaf322}
}
EUVIMED